drugset / Trial / NCT00148460

Trial to Compare the Efficacy and Safety of a Single Bolus of TNK-tPA (Tenecteplase, Metalyse®) With Accelerated Infusion of Rt-PA (Alteplase, Actilyse®) in Asian Patients With Acute Myocardial Infarction

NCT00148460

Phase 3 Completed 270 enrolled Boehringer Ingelheim
RandomizedParallel-groupOpen-labelTreatment

Summary

The objective of this trial was to compare the efficacy and safety of a single bolus of TNK-tPA (tenecteplase, Metalyse®) compared with rt-PA (alteplase, Actilyse®) in Asian patients.

Timeline

Start
2001-03
Primary completion
Completion
2006-02

Drugs

EvaluationDrugModalityDoseRoute
Subject Alteplase Protein / enzyme biologic
Subject Tenecteplase Protein / enzyme biologic

Indications